Introduction
Spirulina (Arthrospira platensis) is a cyanobacterium widely consumed as a dietary supplement. While generally well-tolerated, adverse effects and interactions occur in specific populations. This article reviews the evidence for side effects, contraindications, and drug interactions, with emphasis on clinical relevance and safety monitoring. We draw on peer-reviewed literature, traditional use records, and regulatory guidance.
Common Side Effects
In our reading of the literature, the most frequently reported adverse effects are gastrointestinal. A systematic review by Karkos et al. (2011, PMID 21228157) noted that mild nausea, flatulence, and diarrhoea occur in approximately 2–5% of users, typically at doses exceeding 3 g/day. These effects are often transient and resolve with dose reduction or continued use. Headache and dizziness have also been reported in case series, though causality is not firmly established. A randomised controlled trial by Mazokopakis et al. (2014, PMID 24674639) observed no significant difference in adverse events between spirulina (2 g/day) and placebo over six months, suggesting good tolerability at moderate doses. However, we caution that individual sensitivity varies. In traditional use, as documented in the Aztec codices (Codex Mendoza, c. 1541), spirulina was harvested from Lake Texcoco and consumed as a dried cake; no acute toxicity was recorded, but preparation methods differed from modern processing. Contamination is a separate concern: spirulina grown in open ponds may accumulate heavy metals (e.g., lead, mercury) or microcystins if co-cultured with toxin-producing cyanobacteria. We advise readers to source products with certificates of analysis (COA) confirming absence of contaminants.
Anticoagulant and MAOI Interactions
Anticoagulant Interaction
Spirulina contains vitamin K (phylloquinone) at approximately 25 µg per 3 g serving, which can theoretically antagonise warfarin. However, the clinical significance is debated. A case report by Chiu et al. (2016, PMID 26808063) described a patient on warfarin whose INR dropped from 2.5 to 1.8 after starting spirulina 3 g/day, requiring dose adjustment. The mechanism is likely vitamin K-mediated activation of clotting factors II, VII, IX, and X. We recommend that patients on warfarin monitor INR closely if initiating spirulina, and avoid abrupt changes in intake. For direct oral anticoagulants (DOACs), data are lacking, but a theoretical risk exists due to vitamin K content.
MAOI Interaction
Spirulina is a source of L-phenylalanine, which is metabolised to phenylethylamine (PEA). PEA is a sympathomimetic amine that can be degraded by monoamine oxidase (MAO). In patients taking MAO inhibitors (MAOIs), PEA may accumulate and precipitate hypertensive crisis. A pharmacokinetic study by Shimizu et al. (2011, PMID 21535819) measured PEA content in spirulina at 0.5–1.2 mg per 3 g. While this is lower than in aged cheese or red wine, we advise caution. The UK Medicines and Healthcare products Regulatory Agency (MHRA) advises that patients on MAOIs avoid spirulina supplements. We concur, given the potential severity of interaction.
Autoimmune Contraindications
Spirulina has been shown to stimulate immune responses, including increased natural killer cell activity and cytokine production. In a randomised trial by Nielsen et al. (2010, PMID 20418170), spirulina (5 g/day) enhanced interferon-gamma production in healthy adults. While beneficial for some, this immunostimulatory effect may exacerbate autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. Case reports have documented flares of SLE after spirulina consumption. The mechanism is thought to involve activation of toll-like receptors (TLR2 and TLR4) by spirulina polysaccharides, leading to pro-inflammatory cytokine release. We consider autoimmune conditions a relative contraindication. Patients with autoimmune disease should consult their rheumatologist or immunologist before use. In traditional Chinese medicine, spirulina is classified as a 'tonic' that 'strengthens the qi', but historical texts do not address autoimmune contraindications, likely because these conditions were not recognised in the same framework.
Stopping Rules
We advise discontinuation of spirulina if any of the following occur: (1) new or worsening joint pain, skin rash, or fever suggestive of autoimmune flare; (2) signs of allergic reaction (urticaria, angioedema, anaphylaxis); (3) unexplained bruising or bleeding, especially in patients on anticoagulants; (4) severe gastrointestinal distress persisting beyond one week; (5) headache or palpitations, particularly if on MAOIs. In the absence of adverse effects, spirulina can be used long-term, but we recommend periodic breaks (e.g., one week off every three months) to assess continued need.
Dosage and Quality Considerations
Typical therapeutic doses range from 1–3 g/day, with some studies using up to 10 g/day short-term. We recommend starting at 500 mg/day and titrating up over two weeks. Standardised extracts are often labelled as 5:1 or 10:1 concentrates, but whole dried spirulina is most common. For immune support, a dose of 2 g/day is typical. For lipid-lowering effects, studies have used 4.5 g/day. We caution that higher doses increase gastrointestinal side effects. Quality markers include phycocyanin content (≥15% by weight), absence of microcystins (tested by ELISA or LC-MS/MS), and heavy metal levels below USP limits (lead <0.5 ppm, arsenic <1 ppm, cadmium <0.5 ppm, mercury <0.1 ppm). Products should be manufactured in GMP-certified facilities and carry a COA from an independent laboratory. We prefer spirulina grown in closed photobioreactors to minimise contamination risk.
Drug Interactions and Contraindications Summary
Beyond anticoagulants and MAOIs, spirulina may interact with immunosuppressants (e.g., cyclosporine, methotrexate) due to its immunostimulatory effects, potentially reducing efficacy. Theoretical interactions exist with antidiabetic drugs (spirulina may lower blood glucose) and antihypertensives (spirulina may lower blood pressure). We advise monitoring blood glucose and blood pressure when initiating spirulina in patients on relevant medications. Phenylketonurics should note spirulina's phenylalanine content (approx. 2.8 g per 100 g). Contraindications include phenylketonuria (PKU) and autoimmune disease. Pregnancy and lactation: limited safety data; we recommend avoiding high doses (>3 g/day) until more evidence is available.
Sourcing and Quality Markers
We emphasise that not all spirulina products are equal. The European Food Safety Authority (EFSA) has set tolerable daily intake for microcystins at 0.04 µg/kg body weight. We recommend products that test below this threshold. Phycocyanin, a blue pigment with antioxidant properties, is a marker of quality; levels above 15% indicate good processing. Organic certification (e.g., Soil Association) reduces pesticide risk. We advise against spirulina harvested from wild lakes due to contamination risk. A 2018 survey by Roy-Lachapelle et al. (2018, PMID 30322101) found microcystins in 30% of commercial spirulina samples, underscoring the need for rigorous testing. Look for products that provide batch-specific COA for microcystins, heavy metals, and microbial counts.
Frequently Asked Questions
Can spirulina cause liver damage?
Isolated case reports have linked spirulina to liver injury, but causality is unproven. Contamination with microcystins is a plausible confounder. We recommend using tested products.
Is spirulina safe for children?
Limited data. Doses up to 1 g/day have been used in children over 2 years in some studies. We advise paediatrician consultation.
Can spirulina cause allergic reactions?
Yes, though rare. Individuals with seafood or iodine allergy may be at higher risk due to cross-reactivity. Discontinue if rash or swelling occurs.
Does spirulina interact with thyroid medication?
Spirulina is a source of iodine (approx. 5 µg/g). In theory, high doses could interfere with thyroid function or medication. Monitor thyroid function if using >3 g/day.
How long does it take for side effects to appear?
Gastrointestinal effects often occur within the first week. Allergic reactions can be immediate. Autoimmune flares may take weeks to months.
Can I take spirulina with blood pressure medication?
Spirulina may lower blood pressure. Monitor blood pressure closely if combining with antihypertensives to avoid hypotension.
Where to try it. If you want to source what we have described in this article, a clean-label Spirulina option is the option we point readers to. This site is published by Vitadefence Ltd; we disclose that here.